Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 17, 2016
Eurofins Genomics has announced the launch of a limited beta program for its new DNA synthesis service for scientists who need small quantities of very high-quality starting material for routine molecular and synthetic biology applications. The ...
read more
Thursday, November 17, 2016
Pharm-Olam International has announced the appointment of Daniel Burgess to the position of Senior Director, Quality and Compliance.
read more
Tuesday, November 15, 2016
Seven Bridges, a biomedical data analysis company, and SolveBio have nnounced the integration of their complementary platforms for genomic data analysis. The integration of Seven Bridges’ platform for cloud-based biomedical data analysis with ...
read more
Tuesday, November 15, 2016
Marken has announced the opening of a new operational hub in Chicago, Illinois. The new hub expands Marken's capabilities in the US Northeast region by joining the existing New York, Boston and Philadelphia locations.
read more
Tuesday, November 15, 2016
Juniper Pharmaceuticals, a women's health therapeutics company, has entered into an agreement with its partner, Allergan to monetize future royalty payments due to Juniper for U.S. sales of Crinone® (progesterone gel). Under the agreement, Juniper ...
read more
Tuesday, November 15, 2016
CutisPharma has announced the opening of a Research and Development center to house the company's expanding R&D team. The new center will provide office and laboratory space to facilitate the company's aggressive plans for developing products for FDA...
read more
Monday, November 14, 2016
PAREXEL International Corporation a global biopharmaceutical services provider, has launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies. LIQUENT InSight® for IDMP™ is the newest module added to ...
read more
Monday, November 14, 2016
Xellia Pharmaceuticals has received notice from the US Food and Drug Administration (FDA) allowing the Company to commence packaging and distribution of drug products at its Cleveland, Ohio facilities.
read more
Friday, November 11, 2016
Almac Group, the global contract pharmaceutical development and manufacturing organization has announced plans to expand its operations in Europe and North America increasing its global headcount to reach 5,000 by 2017.
read more
Thursday, November 10, 2016
Sirona Dx, a supplier of high complexity genomics and proteomics services, has adopted Thermo Fisher Scientific’s Oncomine Focus Assay to run on the Ion PGM System and will expand its drug development and next generation sequencing (NGS) services ...
read more
Thursday, November 10, 2016
Sartorius Stedim Biotech has opened a new bioanalytical and biosafety testing laboratory yesterday in the major biotech hub of Boston, Massachusetts.
read more
Thursday, November 10, 2016
Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, announced the strategic acquisition of Emas Pharma (Emas), a global Clinical Research Organization.
read more
Thursday, November 10, 2016
Evotec AG has announced a novel strategic partnership with the University of Oxford, Oxford University Innovation Ltd, OUI (the university's research commercialization company) and Oxford Sciences Innovation, OSI (the world's largest IP investment ...
read more
Thursday, November 10, 2016
Cell Culture Company (C3), a biopharmaceutical developer and manufacturer, has entered into an agreement with a China-based joint venture to produce a clinical-grade antibody-based therapeutic vaccine targeting pancreatic cancer.
read more
Wednesday, November 09, 2016
Catalent a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced financial results for the first quarter of fiscal year 2017, which ended September 30, 2016.
read more